Clinical Trials on The Performance / Safety of the Celsite® Venous Access Ports
Total 16 results
-
B.Braun Médical - CoE ChasseneuilNot yet recruitingThe Performance / Safety of the Celsite® Venous Access Ports
-
Imperial College LondonJoint Replacement Instrumented Orthopaedics LtdRecruitingFocus: A Multicentre Prospective Clinical Surveillance Study Aims to Assess the Clinical, Functional and Radiological Outcome of the Furlong Evolution® Hip StemUnited Kingdom
-
Ocon Medical Ltd.CompletedTo Assess the Safety, Effectiveness and User Experience of the Scu 300A IUBBulgaria, Romania
-
University of LuganoCompletedGroup 1 (Control): Access to a Static Version of the Website Containing Only Static Features (i.e. Library, First Aid, and FAQ) | Group2 (Intervention) Access to an Interactive Version of the Website Containing Both Static and Interactive FeaturesSwitzerland
-
EndologixActive, not recruitingSafety and Performance of the Nellix Endovascular Sealing SystemGermany, Latvia, Luxembourg, Netherlands, New Zealand, Norway, Sweden, United Kingdom
-
Lee's Pharmaceutical LimitedFidia Farmaceutici s.p.a.CompletedThe Primary Objective of This Study Was to Assess the Efficacy and Safety of Hyaluronic Acid Vaginal Gel in Treating Vaginal Dryness
-
Synergy Health Concepts, Inc.UnknownTo Determine the Safety and Validity of Venous Angioplasty and | Valvuloplasty in the Treatment of CCSVI. In Addition, it Will | Allow Researchers to Sub-classify Valve Morphology in Relation | to Treatment Success. This Will be Evidenced by Venous Patency | Forty-eight Hours by Doppler... and other conditionsUnited States
-
LivaNovaCompletedAssess the Benefits From the AAISafeR/SafeR Algorithm of Symphony 2550 or REPLYTM DR in a Wide Range of Pacemaker Patients.Italy, France, Spain, United States, Germany, United Kingdom
-
Sheba Medical CenterUnknownTo Demonstrate That the Closed Loop System Can be Used Safely Over a Few Consecutive Days. | To Assess Effectiveness in Maintaining Patients' Glucose Levels in the Target Range of 70 to 180 mg/dl, Measured by Blood Glucose Sensor. | To Evaluate the User Experience With a Closed Loop...Israel
-
Ataturk UniversityUnknownThis Study Will Provide Data Comparing Safety of LMWH Versus UFH in the Treatment of Acute PE Cases Who Require Thrombolytic Treatment.Turkey
-
University Of PerugiaUnknownThe Primary Study Objective is to Assess the Efficacy and | Safety of Extended 4-week Heparin Prophylaxis Compared to | Prophylaxis Given for 8±2 Days After Planned Laparoscopic | Surgery for Colorectal Cancer. | The Clinical Benefit Will be Evaluated as the Difference in | the Incidence of... and other conditionsItaly
-
Lotus PharmaceuticalUnknownThe Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg | Plus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks in | Subjects With Type 2 Diabetes Mellitus.Taiwan
-
Wuhan UniversityPeking University; PfizerUnknownThe Primary Evaluation is the Change From Baseline at End of Study for CDSS Total Scores. | The Secondary Efficacy Evaluations Include: MADRS, PANSS Total Scores and Subscales and Responder Rate; CGI-S and CGI-I Scales. | Safety Evaluations Include: Laboratory Test Abnormalities; BARS... and other conditions
-
AstraZenecaNot yet recruitingUsing NCID Database to Assess the Safety of Olaparib in Chinese Patients With Ovarian Cancer by Examining the Incidence, Seriousness, and Severity of All AE
-
Axcella Health, IncCompletedSickle Cell Disease | Anemia, Sickle Cell | Sickle Cell Anemia | To Assess the Safety and Tolerabiltiy of an Amino Acid Composition in Subjects With Sickle Cell Disease | Sickle Cell DisordersUnited States
-
SymBio PharmaceuticalsCompletedAssess the Efficacy and Safety of SyB L-0501 in Combination With Rituximab in Patients With Recurrent or Relapsed DLBCLJapan